These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4187803)

  • 1. [Results of follow-up over 5 years of Basedow's disease under medical management].
    Shizume K
    Nihon Ishikai Zasshi; 1969 Sep; 62(5):435-41. PubMed ID: 4187803
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination of low doses of 131-iodine and synthetic antithyroid agents for prolonged treatment in Basedow's disease. Apropos of 165 cases].
    Mitouze J; Jaffiol C; Baldet L; Ghachem M
    Rev Fr Endocrinol Clin; 1972; 13(4):339-61. PubMed ID: 4122472
    [No Abstract]   [Full Text] [Related]  

  • 3. [Basedow's disease].
    Kumahara Y
    Naika; 1965 Aug; 16(2):332-4. PubMed ID: 4161079
    [No Abstract]   [Full Text] [Related]  

  • 4. [Developmental analysis of 165 cases of Basedow's disease treated with low doses of I-131 associated with synthetic antithyroid drugs in long-term treatment].
    Jaffiol C; Baldet L; Ghachem M; Mirouze J
    Ann Endocrinol (Paris); 1972; 33(2):148-50. PubMed ID: 4118100
    [No Abstract]   [Full Text] [Related]  

  • 5. [Surgical management and prognosis of Basedow's disease].
    Ezaki H; Shigemitsu T; Araki M; Sasao T; Maruyama K
    Geka Chiryo; 1969 Nov; 21(5):534-41. PubMed ID: 4187614
    [No Abstract]   [Full Text] [Related]  

  • 6. [Basedow's disease].
    Shizume K
    Naika; 1971 Jun; 27(6):1156-8. PubMed ID: 4103929
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy of Basedow's disease. Long term functional results (302 cases)].
    Scazziga BR
    Schweiz Med Wochenschr; 1977 Apr; 107(13):423-7. PubMed ID: 66747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proceedings: Effect of the volume of iodine uptake on recurrence of Basedow's disease: in patients with suppression of iodine uptake due to actions of antithyroid agents].
    Nagataki S; Uchimura H; Ikeda H; Matsuzaki F; Imai Y
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):409. PubMed ID: 4141671
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
    Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proceedings: Recovery rate in Basedow's disease treated with thyroid antagonists: frequency of development of suppression 1 year after the initiation of the treatment].
    Nagataki S; Uchimura H; Ikeda H; Matsuzaki F; Imai Y
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):424. PubMed ID: 4141673
    [No Abstract]   [Full Text] [Related]  

  • 11. [Place of iodotherapy in the medical treatment of Basedow's disease].
    Gilbert-Dreyfus
    Therapeutique; 1971 Apr; 47(4):347-9. PubMed ID: 4105094
    [No Abstract]   [Full Text] [Related]  

  • 12. [Basedow's disease. 1. Drug therapy of hyperthyroidism].
    Tourniaire J
    Lyon Med; 1971; 18():Suppl:48-51. PubMed ID: 4105819
    [No Abstract]   [Full Text] [Related]  

  • 13. [Proceedings: Effect of inorganic iodine on serum thyroxine concentration in Basedow's disease--in patients during treatment with antithyroid agents].
    Ikeda H; Imai Y; Uchimura H; Matsuzaki F; Nagataki S
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):408. PubMed ID: 4141670
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current concepts in the treatment of Basedow's disease].
    Jaffiol C; Baldet L
    Sem Hop; 1975 Sep 10-20; 51(37-38):2265-7. PubMed ID: 56038
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug therapy in Basedow's disease].
    Scazziga BR
    Rev Med Suisse Romande; 1978 May; 98(5):243-9. PubMed ID: 78516
    [No Abstract]   [Full Text] [Related]  

  • 16. [Basedow's disease in children].
    Nakajima H; Niimi H
    Nihon Rinsho; 1971 May; 29(5):1355-9. PubMed ID: 4103637
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of Basedow's disease].
    Bürgi H
    Rev Med Suisse Romande; 1975 May; 95(5):325-43. PubMed ID: 52173
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies of the action of prenylamine in Basedow's disease before, during and after treatment with iodine-131].
    Riviere J; Latapie JL; Roger P; Blein JP
    Rev Fr Endocrinol Clin; 1969; 10(5):Suppl:1-4. PubMed ID: 5395882
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combination of low doses of iodine 131 and synthetic antithyroid drugs in long-term care of Basedow's disease. Its value in the prevention of secondary hypothyroidism. (Apropos of 165 cases)].
    Jaffiol C; Baldet L; Ghachem M; Robin M; Mirouze J
    Sem Hop; 1973 Feb; 49(10):683-92. PubMed ID: 4122346
    [No Abstract]   [Full Text] [Related]  

  • 20. [Basedow's disease. Individual therapy of is great significance].
    Hörmann R
    MMW Fortschr Med; 2005 Sep; 147(35-36):47. PubMed ID: 16180573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.